GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.
from WSJ.com: US Business https://ift.tt/2Ryf5s6
via IFTTT
No comments:
Post a Comment